Skip to main content
© Institut Pasteur de Shangai

Research program on respiratory illnesses

with the Institut Pasteur of Shanghai

Respiratory illnesses are a major public health issue in China. They are notably the leading cause of infant mortality. Improving diagnostic competencies would make it possible to treat patients more efficiently; today, 40% of all respiratory ailments in Shanghai have not been identified. The Air Liquide Foundation supports Institut Pasteur of Shanghai to advance research on the identification and prevention of this respiratory pathologies.

The research project

The research project of Institut Pasteur of Shanghai meets the need for the development of molecular biology techniques to establish more rapid and efficient medical diagnoses in the treatment of respiratory infections. The diagnostic units use “biological microchips”, a new molecular biology technology. The researchers of Institut Pasteur of Shanghai hope to discover many new viruses and develop more efficient diagnostic methods to improve the treatment of these illnesses.

The research program provides for:

  • The study of a patient population, with the aim of developing a sampling and treatment method for biological samples
  • The standardization of the methodology for using microchips
  • The creation of a data base on the new infectious agents detected.

A better knowledge of the causes and factors of these infections will permit, in the longer term, the development of a system for monitoring and preventing epidemics in collaboration with the Chinese public health authorities.

The Institut Pasteur of Shangai

Institut Pasteur of Shanghai was created in 2004 in the framework of a partnership with the Chinese Academy of Sciences and the City of Shanghai. It is part of the Asian network of Institut Pasteur for monitoring respiratory viruses whose aim is to develop high-level research on infectious pathologies.
Institut Pasteur of Shanghai contributes, through its expertise, to decision-making by the Chinese authorities in the monitoring and prevention of epidemics. The Institute is notably a part of the alert system established by the City of Shanghai with a view to the 2010 World Fair.

PROJECT IDENTITY

  • Project initiator: Institut Pasteur of Shanghai
  • Location: Shanghai, China
  • Year of support: 2008
  • Air Liquide Sponsor : Stephane ASCARATEIL, Marketing & Development, Business Unit Human Health SEPPIC, a subsidiary of the Air Liquide Group